Funds holding ERNEXA THERAPEUTICS INC
ISIN US1140823089 · United States
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- ≈ 26.7K $ 10.6K $ · 13.7K €
- Share of capital
- 2.8 % of 1.6M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 26,504 | 5.3K $ | 1.62 % | as of Mar 31, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 15,233 | 4.3K $ | 0.93 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 3,193 | 910.3 $ | 0.20 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 136 | 38.8 $ | 0.01 % | as of Feb 28, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 49 | 9.8 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| CINVEST,FI CINVEST/ AZERO GLOBAL GESALCALA, S.A., S.G.I.I.C. | 13.7K € | 0.98 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| CINVEST,FI CINVEST/ AZERO GLOBAL GESALCALA, S.A., S.G.I.I.C. | 0.98 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | 0 | 45,115 | +68.6 % |
| 2026Q1 | 5 | +1 | 26,766 | -0.2 % |
| 2025Q4 | 4 | +3 | 26,809 | +1,148.7 % |
| 2025Q3 | 1 | 2,147 |
Institutional managers
17 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Bleichroeder LP | 2,000,000 | 398K $ | as of Mar 31, 2026 |
| Dauntless Investment Group, LLC | 612,443 | 121.9K $ | as of Mar 31, 2026 |
| Corient Private Wealth LLC | 438,093 | 87.2K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 244,446 | 48.6K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 54,338 | 10.8K $ | as of Mar 31, 2026 |
| Warberg Asset Management LLC | 50,000 | 10.1K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 41,167 | 8.2K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 33,076 | 6.6K $ | as of Mar 31, 2026 |
| UBS Group AG | 21,233 | 4.2K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 16,631 | 3.3K $ | as of Mar 31, 2026 |
| Sippican Capital Advisors | 10,000 | 2K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 820 | 163 $ | as of Mar 31, 2026 |
| ASSETMARK, INC | 133 | 26 $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 10 | 2 $ | as of Mar 31, 2026 |
| MONTAG A & ASSOCIATES INC | 8 | 2 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 6 | 1 $ | as of Mar 31, 2026 |
| Activest Wealth Management | 3 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of ERNEXA THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Bleichroeder LP and 2 others | 6.86 % | 80,000 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ERNEXA THERAPEUTICS INC". https://titelia.com/en/stocks/ernexa-therapeutics-inc-US1140823089